Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miguel Martin

Showing results (101-110 of 312) with videos related to

Pageof 32
Sort By:
Cadernos De Saude Publica|December 11, 2025
Avoidable hospitalizations for ambulatory care sensitive conditions in children under five years in Ecuador, 2000-2023Carolina Buñay-Morocho, Pablo Álvarez, Daniel Zurita, et al.
Journal of Clinical Pathology|May 28, 2020
Nephrotic syndrome in a 60-year-old manMiguel Garcia Pardo, Inmaculada Aparicio, Marta Arregui, et al.
JCO Precision Oncology|November 3, 2023
Unleashing a Lazarus Effect With Selpercatinib in a Never-Smoker Patient With Stage IV, Chemo-Immunotherapy Refractory, <i>RET</i> C630Y-Mutant, Small-Cell Lung Cancer: A First Case ReportAntonio Calles, Marta Arregui, Julia Suárez-González, et al.
Breast (Edinburgh, Scotland)|January 12, 2018
First-line vs second-line fulvestrant for hormone receptor-positive advanced breast cancer: A post-hoc analysis of the CONFIRM studyAngelo Di Leo, Guy Jerusalem, Roberto Torres, et al.
Scientific Reports|January 10, 2017
Two-Step Amyloid Aggregation: Sequential Lag Phase IntermediatesFabio Castello, Jose M Paredes, Maria J Ruedas-Rama, et al.
Future Oncology (London, England)|July 18, 2024
Abemaciclib plus endocrine therapy for HR+, HER2-, node-positive, high-risk early breast cancer: a plain language summary of the monarchE studyStephen R D Johnston, Hope S Rugo, Sara M Tolaney, et al.
Annals of Vascular Surgery|February 22, 2026
THREE-DIMENSIONAL ULTRASOUND FOR ABDOMINAL AORTIC ANEURYSM SURVEILLANCE: DIAGNOSTIC ACCURACY, REPRODUCIBILITY, AND AGREEMENT WITH CT. A SYSTEMATIC REVIEW AND META-ANALYSISM Lourdes Del Río-Solá, Joan Roedan-Oliver, Sergio Asensio-Rodriguez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2010
BCIRG 001 molecular analysis: prognostic factors in node-positive breast cancer patients receiving adjuvant chemotherapyCharles Dumontet, Maryla Krajewska, Isabelle Treilleux, et al.
Journal of Vascular Surgery. Venous and Lymphatic Disorders|September 5, 2025
THE CARDIOVASCULAR IMPACT OF CHRONIC VENOUS DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSISMaria Lourdes Del Río-Solá, Noelia Cenizo-Revuelta, Saiz Viloria Laura, et al.
Future Oncology (London, England)|August 13, 2020
Abemaciclib, a CDK4 and CDK6 inhibitor for the treatment of metastatic breast cancerMiguel Martin, Jose A Garcia-Saenz, Luis Manso, et al.
Pageof 32

Showing results (101-110 of 312) with videos related to

Sort By:
Pageof 32
Cadernos De Saude Publica|December 11, 2025
Avoidable hospitalizations for ambulatory care sensitive conditions in children under five years in Ecuador, 2000-2023Carolina Buñay-Morocho, Pablo Álvarez, Daniel Zurita, et al.
Journal of Clinical Pathology|May 28, 2020
Nephrotic syndrome in a 60-year-old manMiguel Garcia Pardo, Inmaculada Aparicio, Marta Arregui, et al.
JCO Precision Oncology|November 3, 2023
Unleashing a Lazarus Effect With Selpercatinib in a Never-Smoker Patient With Stage IV, Chemo-Immunotherapy Refractory, <i>RET</i> C630Y-Mutant, Small-Cell Lung Cancer: A First Case ReportAntonio Calles, Marta Arregui, Julia Suárez-González, et al.
Breast (Edinburgh, Scotland)|January 12, 2018
First-line vs second-line fulvestrant for hormone receptor-positive advanced breast cancer: A post-hoc analysis of the CONFIRM studyAngelo Di Leo, Guy Jerusalem, Roberto Torres, et al.
Scientific Reports|January 10, 2017
Two-Step Amyloid Aggregation: Sequential Lag Phase IntermediatesFabio Castello, Jose M Paredes, Maria J Ruedas-Rama, et al.
Future Oncology (London, England)|July 18, 2024
Abemaciclib plus endocrine therapy for HR+, HER2-, node-positive, high-risk early breast cancer: a plain language summary of the monarchE studyStephen R D Johnston, Hope S Rugo, Sara M Tolaney, et al.
Annals of Vascular Surgery|February 22, 2026
THREE-DIMENSIONAL ULTRASOUND FOR ABDOMINAL AORTIC ANEURYSM SURVEILLANCE: DIAGNOSTIC ACCURACY, REPRODUCIBILITY, AND AGREEMENT WITH CT. A SYSTEMATIC REVIEW AND META-ANALYSISM Lourdes Del Río-Solá, Joan Roedan-Oliver, Sergio Asensio-Rodriguez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2010
BCIRG 001 molecular analysis: prognostic factors in node-positive breast cancer patients receiving adjuvant chemotherapyCharles Dumontet, Maryla Krajewska, Isabelle Treilleux, et al.
Journal of Vascular Surgery. Venous and Lymphatic Disorders|September 5, 2025
THE CARDIOVASCULAR IMPACT OF CHRONIC VENOUS DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSISMaria Lourdes Del Río-Solá, Noelia Cenizo-Revuelta, Saiz Viloria Laura, et al.
Future Oncology (London, England)|August 13, 2020
Abemaciclib, a CDK4 and CDK6 inhibitor for the treatment of metastatic breast cancerMiguel Martin, Jose A Garcia-Saenz, Luis Manso, et al.
Pageof 32